A Study to Determine the Safety and Efficacy of TG-C in Subjects with Symptomatic Early Hip Osteoarthritis
NCT05276011
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
255
Enrollment
INDUSTRY
Sponsor class
Conditions
Degenerative Osteoarthritis
Interventions
BIOLOGICAL:
TG-C
BIOLOGICAL:
Placebo Control
Sponsor
Kolon TissueGene, Inc.